Aleafia Health Announces Fourth Quarter and Annual Financial Results
-- Revenue increased 9% to $11.7 million for the period ended March 31, 2023 ("Q4 FY2023") versus $10.7 million for the period ended March 31, 2022 -- Net revenue increased 33% to $9.4 million for Q4 FY2023 versus $7.0 million for the period ended March 31, 2022 -- Revenue increased 24% to $57.4 million for the 12 months ended March 31, 2023 ("FY2023") over the twelve months ended March 31, 2022 -- Net revenue increased 19% to $42.8 million for FY2023 over the twelve months ended March 31, 2022 -- #5 and #2 market share ranking in Divvy pre-roll and milled product formats in Q4 FY2023 in Ontario1 -- 318% growth in international net revenue2 in FY2023 over the twelve months ended March 31, 2022 -- Third consecutive quarter of positive Adjusted EBITDA3 achieved in Q4 FY2023 TORONTO, June 14, 2023 (GLOBE NEWSWIRE) --
Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) ("Aleafia Health" or "Aleafia" or the "Company") is pleased to report its audited financial results for the three and twelve months ended March 31, 2023 ("FY2023").
During the fourth quarter of the 2023 fiscal year, ending March 31, 2023, there was a total revenue increase of 9% to $11.7 million from $10.7 in the quarter ending March 31, 2022 while net revenue in Q4 FY2023 increased by 33%, to $9.4 million from $7.0 million in the comparable quarter last year.